Renalytix Plc (AIM:RENX)
London
· Delayed Price · Currency is GBP · Price in GBX 8.25
+0.25 (3.03%)
May 13, 2025, 4:35 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 27.32 million as of May 13, 2025. Its market cap has decreased by -26.25% in one year.
Market Cap
27.32M
Enterprise Value
26.19M
Revenue
2.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.25
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 27.32M, a decrease of -57.69%. That is a compound annual growth rate of -12.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.28B |
| GSK plc | 55.98B |
| Haleon | 36.42B |
| Smith & Nephew | 9.45B |
| ConvaTec Group | 5.36B |
| Hikma Pharmaceuticals | 4.31B |
| HUTCHMED (China) | 1.83B |
| Genus | 1.39B |